Abstract
Brain tumors, which are abnormal growths of cells in the brain, represent a significant health concern, necessitating prompt and accurate detection for effective treatment. If left untreated, brain tumors can lead to severe complications, including cognitive impairment, paralysis, and even death. This study evaluates six machine learning classifiers: Support Vector Classifier (SVC), Logistic Regression Classifier, K-Nearest Neighbors (KNN) Classifier, Naive Bayes Classifier, Decision Tree Classifier, and Random Forest Classifier - on a comprehensive brain tumor dataset. Our results showed that Random Forest achieved the highest accuracy of 98.27%, demonstrating its potential in detecting brain tumors. However, Support Vector Classifier (SVC) emerged as the top performer, achieving an impressive accuracy of 97.74%, showcasing its exceptional ability to detect brain tumors accurately. This significant improvement in SVC’s performance highlights its potential as a reliable tool for medical diagnostics, contributing to the development of efficient and accurate automated systems for early brain tumor diagnosis, ultimately aiming to improve patient outcomes and treatment efficacy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.kaggle.com/datasets/jakeshbohaju/brain-tumor
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Dataset downloaded from: https://www.kaggle.com/datasets/jakeshbohaju/brain-tumor Brain Tumor Detection Model file uploaded link: https://github.com/1umairali/models/tree/main/brain_tumor_detection
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
https://www.kaggle.com/datasets/jakeshbohaju/brain-tumor
